
Steven J Durham
Labaton Sucharow LLP, USA
Title: Corporate integrity in the medical research and pharmaceuticals industries: The SEC’s Whistleblower Program
Biography
Biography: Steven J Durham
Abstract
In 2010, the Dodd-Frank reform legislation created the SEC Whistleblower Program as a key tool in the SEC’s enforcement framework. Since its inception, the SEC’s Offi ce of the whistleblower has awarded 50 whistleblowers over $160 million for information that has led to many signifi cant SEC enforcement actions. In this keynote address, Labaton Sucharow partner Steven J. Durham will discuss the operation and success of the SEC Whistleblower Program and how every individual plays an important role in protecting corporate integrity.